US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Bitfarms Ltd (BITF)
Bitfarms Ltd (BITF) オプション

Bitfarms Ltd (BITF)

1.98

0.00

(0.00%)

終了 7月12日 5:00AM

0.00

0.00

(0.00%)

取引時間後: -

Bitfarms Ltd ([symbol]) オプションチェーン

BITF ライブオプションフロー

オプションコール

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
0.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
1.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
1.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
2.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
3.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
3.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
4.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
4.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

個人投資家向けのプロ仕様のツール。

プレミアム

オプションプット

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
0.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
1.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
1.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
2.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
3.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
3.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
4.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
4.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
GMMGloba Mofy AI Ltd	US$ 4.57 (147.03%)	138.58M
JZXNJiuzi Holdings Inc	US$ 2.165 (85.04%)	146.27M
NVVENuvve Holding Corporation	US$ 13.50 (53.76%)	18.16M
AARDAardvark Therapeutics Inc	US$ 7.66 (53.20%)	4.09M
SUNESUNation Energy Inc	US$ 3.8201 (49.22%)	75.99M
HAOHaoxi Health Technology Ltd	US$ 0.3525 (-67.06%)	93.04M
JEM707 Cayman Holdings Ltd	US$ 0.54 (-51.79%)	7.76M
ELPWElong Power Holding Ltd	US$ 0.3003 (-46.94%)	92.78M
VRAXVirax Biolabs Group Ltd	US$ 4.08 (-35.85%)	1.75M
AFJKUAimei Health Technology Company Ltd	US$ 18.00 (-35.74%)	2
ZBAOZhibao Technology Inc	US$ 0.422 (42.57%)	325.25M
DFNST3 Defense Inc	US$ 0.117427 (-20.12%)	288.79M
NVDANVIDIA Corporation	US$ 210.96 (4.03%)	149.34M
JZXNJiuzi Holdings Inc	US$ 2.165 (85.04%)	146.27M
GMMGloba Mofy AI Ltd	US$ 4.57 (147.03%)	138.58M

Lifetime

Lifetime 2分前

FFS please, please learn what revenue, gross profit, net profit and COGS mean. GREATNESS from learning basic finance terms

BlueSky195

BlueSky195 6分前

You don’t have a clue what is really going on, quit spewing your wild guess's. Watcher too, just stop with your rambling speculations.

Truthsocial

Truthsocial 7分前

Current Status and Next Steps
Vivos Inc. received FDA Investigational Device Exemption (IDE) approval for its RadioGel study on July 6, 2026. This clearance allows the company to initiate its first-in-human feasibility study at Mayo Clinic in Jacksonville, Florida. However, the study cannot

12yearplan

12yearplan 8分前

'NAH!" ??????????????????????????

was the exclamation point really necessary????????????????? !

If I understand all that previous interest discussion even half correctly I think you may have that characteristic wise and witty trading strategy still in tow and that you m

condor1

condor1 8分前

Biased Beeny, while you often make good arguing points, as to legal pleadings, I know a lot, while conversely, you have demonstrated that you know very little.
Applebaum isforming his pleading like most, if not all attorneys. There is a second cause of action after the first cause of act

havnagoodtime

havnagoodtime 10分前

It is for the benefit of whoever follows along.

My hand is raised. Thank you for your time and effort.

reachjo

reachjo 10分前

My bet is by early September, maybe sooner.

Doc logic

Doc logic 14分前

manibiotech,

Maybe we should all just focus on the manufacturing updates because until then, and getting off of OTC with partnership news, the question will be about manufacturing profitably and ability to ramp up even after an approval without that news. Approval is great but partne

Jlo32

Hey Tenkay check out Greg on LinkedIn

mrsdoubtfire

mrsdoubtfire 17分前

well as far as i know vakster stepped down

ListenToTheTrees

ListenToTheTrees 19分前

You’re entitled to your opinion, but labeling anyone who disagrees with you an “apologist” doesn’t strengthen your argument.

You say your facts haven’t been refuted, but that’s not really the issue. The debate has always been about the conclusions you draw from those facts.

goodietime

goodietime 23分前

goodietime

goodietime 23分前

TenKay

TenKay 25分前

You are forever going to be an apologist for this scam…for whatever reason. For some time I thought you were Foote because of the manner in which you started engaging on the board. I no longer believe that because I was waiting for you to jump to the $1.5 million which you never did. I don’t thin

Eths

SNTX
https://x.com/javilealoficial/status/2076084288324284708?s=46&t=6Y7w8L7iBETCgMYpIXWuzg

Eths

SNTX
https://x.com/javilealoficial/status/2076084288324284708?s=46&t=6Y7w8L7iBETCgMYpIXWuzg

Jack_White_3

Jack_White_3 28分前

Jah man. Fobi50
See ya around.

https://youtu.be/4_B4PtwE-QA?si=OsvokbUT6kP8RoPq

mascale

mascale 29分前

Company investments Potential a driver of stock value.

manibiotech

manibiotech 29分前

And you have audacity to come back and criticize others

How about theory of “ very last stage of labeling”

Lsmith500

Lsmith500 31分前

https://x.com/javilealoficial/status/2076084288324284708?s=46

WebSlinger

WebSlinger 34分前

>

And it would only cost $2,000 and fall apart in the rain!

LOL

PickStocks

PickStocks 34分前

Quote: “ ***There was an ownership Change on 3/19/2012 that canceled ALL former Preferred and Common Prospectuses along with ALL associated documents. Here take a look***
Understand POR 6 and KNOW the changes/facts in Amended POR 7 approved by the court on 2/23/2012 plus the 8K Filing on 8/1/

PickStocks

PickStocks 36分前

Quote: “ Liquidating Trust Interests (which hold the residual value of tax attributes and litigation settlements) move down the waterfall to equity holders.” all or if any money was sent to the WMILT for distribution if there was any. .. which was donated with what was left……

Eli's Gone

Eli's Gone 36分前

Sprott Physical Copper

Guggenheim Credit Alloca...

2.495% Unsubord Pr Dbt I...

Bmo Target Education 202...

Amundi Stoxx EU Technology

Corcept Therapeutics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。